Duke Cancer Center Lands Renewal of $30 Million Grant

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 19 No 12
Volume 19
Issue 12

The Duke Comprehensive Cancer Centerin Durham, N.C., has received a five-year,$30 million core grant renewal from NCIto support its clinical, research, and educationalprograms.

The Duke Comprehensive Cancer Center in Durham, N.C., has received a five-year, $30 million core grant renewal from NCI to support its clinical, research, and educational programs. The award means the center retains its designation as one of 40 U.S. cancer institutions deemed “comprehensive” by the NCI.

“This renewal comes at an exciting and transformative time in the history of cancer research, treatment, and teaching within Duke medicine and supports Duke’s national reputation for excellence in cancer care,” said Victor J. Dzau, MD, chancellor of health affairs and CEO, Duke Health System.

The grant comes at a time when Duke is expanding its cancer program through additional local, regional and statewide affiliations and building a new, state-of-theart, multidisciplinary cancer care center scheduled to open in early 2012.

The Duke Comprehensive Cancer Center was established in 1972 and has benefited from continuous recognition and funding from the NCI since 1973, when it was named as one of the original eight comprehensive cancer centers.

In other news, H. Kim Lyerly, MD, director of the Duke Comprehensive Cancer Center, has been appointed to serve on two councils at NIH: the Council of Councils, which advises the NIH director on the policies and activities of the division of program coordination, planning, New Jersey cancer center features green lobby The John Theurer Cancer Center at Hackensack University Medical Center in New Jersey opened its new $130-million comprehensive care facility. The cancer center building will house 14 specialized divisions, including research and auxiliary oncology services, nutrition counseling, psychosocial support, and complementary therapies. The centerpiece of the lobby is a “living wall” with a 24-foot waterfall and more than 30 hydroponically grown plant species (above). The project was funded with $65 million raised by the Hackensack University Medical Center and with a $10 million donation from Helena Theurer, in memory of her husband John Theurer. n and strategic initiatives, and the Office of AIDS Research Advisory Council, which guides several federal entities on AIDS policy.

References:

Reporting by Shalmali Pal

Recent Videos
Lisa J. States, MD, discussed further steps for improving early detection and screening methods in patients with Li–Fraumeni syndrome.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
9 Experts are featured in this series.
9 Experts are featured in this series.
Additional genetic testing measures and targeted therapies may improve outcomes for patients with diverse molecular subgroups of gastric cancers.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
Related Content